REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 401 filers reported holding REPLIGEN CORP in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,098,918 | +56.9% | 6,911 | +39.6% | 0.00% | +33.3% |
| Q2 2023 | $700,227 | +23.8% | 4,950 | +47.4% | 0.00% | +50.0% |
| Q1 2023 | $565,521 | -8.3% | 3,359 | -7.8% | 0.00% | -33.3% |
| Q4 2022 | $616,628 | -14.5% | 3,642 | -5.5% | 0.00% | -25.0% |
| Q3 2022 | $721,000 | +84.4% | 3,856 | +60.2% | 0.00% | +33.3% |
| Q2 2022 | $391,000 | -45.0% | 2,407 | -36.3% | 0.00% | -40.0% |
| Q1 2022 | $711,000 | -6.3% | 3,780 | +32.0% | 0.01% | 0.0% |
| Q4 2021 | $759,000 | -12.1% | 2,864 | -4.1% | 0.01% | -28.6% |
| Q3 2021 | $863,000 | +40.3% | 2,987 | -3.0% | 0.01% | +16.7% |
| Q2 2021 | $615,000 | +2.3% | 3,080 | -0.4% | 0.01% | -14.3% |
| Q1 2021 | $601,000 | +18.5% | 3,092 | +16.9% | 0.01% | 0.0% |
| Q4 2020 | $507,000 | +94.3% | 2,646 | +51.7% | 0.01% | +75.0% |
| Q3 2020 | $261,000 | +91.9% | 1,744 | +59.0% | 0.00% | +100.0% |
| Q2 2020 | $136,000 | – | 1,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |